Short description
Elastrin Therapeutics is a biotech company developing novel therapies to reverse cardiovascular disease.
Description
Elastrin Therapeutics is a biotech startup with technologies to restore hardened and damaged arteries & tissue by targeting the elastic fiber that makes them work.
The company's proprietary platform that targets and restores degraded elastin by removing the harmful calcification that stiffens arteries. The platform significantly improves the efficacy of drugs and eliminates side effects by combining particle design with elastin targeting.
Total funding
$$121212
Sign in for full access
Location
Simpsonville, South Carolina, United States, North America
Founded on
January 1, 2017
Non-profit?
No
Acquired?
No
Employees count
1-10
Investors
Blurry Noaccess, Nopepepe, Nopepepe
Sign in for full access
Founders
Douglas Mulhall, Naren Vyavahare